Effects of Switching From Anastrozole to Letrozole, Due to Reimbursement Policy, on the Outcome of Breast Cancer Therapy

Breast Cancer: Targets and Therapy - New Zealand
doi 10.2147/bctt.s67553
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Informa UK Limited

Related search

A Comparison of Letrozole and Anastrozole Followed by Letrozole in Breast Cancer Patients

Breast Cancer: Targets and Therapy
Oncology
2015English

Letrozole Is Superior to Anastrozole in Suppressing Breast Cancer Tissue and Plasma Estrogen Levels

Clinical Cancer Research
Cancer ResearchOncology
2008English

Anastrozole May Aid Breast Cancer Prevention

Cancer Discovery
Oncology
2013English

Anastrozole as Aromatase Inhibitor – New Approaches to Breast Cancer Treatment in Postmenopausal Women

Nowotwory
Cancer ResearchOncology
2019English

Irreversible Heart Failure Related to Adjuvant Anastrozole in a Patient With Breast Cancer

Akdeniz Medical Journal
2017English

Hypoxia and Oxidative Stress in Breast Cancer Oxidative Stress - Its Effects on the Growth, Metastatic Potential and Response to Therapy of Breast Cancer

Breast Cancer Research
Cancer ResearchOncology
2001English

How to Improve Endocrine Therapy of Breast Cancer

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
1990English

The Immunogenicity to the First Anti-TNF Therapy Determines the Outcome of Switching to a Second Anti-TNF Therapy in Spondyloarthritis Patients

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2013English

Pictilisib Plus Anastrozole Reduces Proliferation in ER+ Breast Cancer

Cancer Discovery
Oncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy